Arş. Gör. Dr. Semra Cemre ATALAR

Yayın Ağı

Makaleler 10

1. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications

Özge A., Baykan B., BIÇAKCI Ş., Ertaş M., Atalar A., Gümrü S., et al.

Frontiers in Neurology , cilt.15, 2024 (SCI-Expanded)

2. P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

Atalar S. C.

HemaSphere , cilt.1, ss.1, 2023 (SCI-Expanded)

3. Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era

Atalar S. C.

BLOOD , cilt.140, ss.9554-9556, 2022 (SCI-Expanded)

4. P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

Atalar S. C.

HemaSphere , cilt.6, ss.1114-1115, 2022 (SCI-Expanded)

5. Abstract 6255: CRISPRa-mediated induction of apoptosis in therapy-resistant glioblastoma cells via derepression of pro-apoptotic genes

Yilmaz E., Kayabolen A., Atalar S. C., Yigit B., Ulukan B., Zeybel M., et al.

CANCER RESEARCH , cilt.82, sa.12_Supplement, ss.1, 2022 (SCI-Expanded)

6. Severe vitamin D deficiency is associated with endothelial inflammation in healthy individuals even in the absence of subclinical atherosclerosis

Kose M., Senkal N., Tukek T., Cebeci T., Atalar S. C., Altinkaynak M., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , sa.19, ss.7046-7052, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES

Vassilakopoulos T., Ferhanoglu B., Horowitz N., Mellios Z., Kaynar L., Zektser M., et al.

HEMATOLOGICAL ONCOLOGY , cilt.39, sa.S2, ss.1, 2021 (SCI-Expanded)

8. Intravascular Large B-Cell Lymphoma Within the Appendix Presenting as Acute Abdomen: A Challenging Diagnosis for Hematologists

Atalar S. C., Akay O. M., Osmanbasoglu E., Masyan H., Taskin O. C., Ferhanoglu B.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.89-91, 2021 (SCI-Expanded)

9. Role of miRNAs in immune responses and immunotherapy in cancer

Cortez M. A., Anfossi S., Ramapriyan R., Menon H., Atalar S. C., Aliru M., et al.

GENES CHROMOSOMES & CANCER , cilt.58, sa.4, ss.244-253, 2019 (SCI-Expanded)

10. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment

Menon H., Ramapriyan R., Cushman T. R., Verma V., Kim H. H., Schoenhals J. E., et al.

FRONTIERS IN IMMUNOLOGY , cilt.10, 2019 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

1. DÜŞÜK EJEKSİYON FRAKSİYONLU KALP YETERSİZLİĞİ İLE BAŞVURAN GENÇ KADIN HASTA; SOL VENTRİKÜLER NONCOMPACTİON KARDİYOMİYOPATİSİ

ATALAR S. C., GÖKSOY SOLAK Y., ALTINKAYNAK M., KARAAYVAZ E. B., AKPINAR T. S., SAKA B., et al.

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2023, Sakarya, Türkiye, 9 - 12 Mart 2023, ss.46-47, (Tam Metin Bildiri)

2. COVID-19 ve aşıları ile ilişkili rekürren perikardit olguları

Yılmaz A., Çetin O., Alagöz G., Atalar S. C., Amikishiyev S., Göksoy Solak Y., et al.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 - 30 Ekim 2022, cilt.14, sa.89, ss.265, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. COVID-19 ENFEKSİYONU SONRASI TEKRARLAYAN, ANTİ-IL-1 TEDAVİSİNE YANITLI BİR PLÖROPERİKARDİT TABLOSU: OLGU SUNUMU

ATALAR S. C., ÇETİN O., GÖKSOY SOLAK Y., ALTINKAYNAK M., AMIKISHIYEV S., AKPINAR T. S., et al.

İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2022, Sakarya, Türkiye, 24 - 27 Mart 2022, ss.93-94, (Tam Metin Bildiri)